Omnia SanaPlant Comparison
Perforate St John’s-wort vs Lemon balm
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Perforate St John’s-wort and Lemon balm: they share 6 indicated uses (arthritis / joint pain, cold & flu, infection (general), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Perforate St John’s-wort | Lemon balm | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Lemon balm |
| Cold & flu | 1/10 | 8/10 | Stronger for Lemon balm |
| Infection (general) | 1/10 | 8/10 | Stronger for Lemon balm |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Lemon balm |
| Insomnia / sleeplessness | 1/10 | 5/10 | Stronger for Lemon balm |
| Skin irritation | 1/10 | 5/10 | Stronger for Lemon balm |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Red pigments historically used to standardise extracts; contribute to antiviral activity and are the compounds responsible for photosensitivity risk.
Considered the principal compound behind the antidepressant activity and the main driver of the herb's potent CYP3A4/P-glycoprotein induction and drug-interaction profile.
Antioxidant flavonoids contributing to overall activity.
The principal phenolic acid of lemon balm, associated with much of its antioxidant and antiviral activity.
The volatile oil (geranial and neral, together called citral, plus citronellal) gives the characteristic lemon scent and has demonstrated anxiolytic activity.
Minor constituents studied for anti-inflammatory activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
Safety, Cautions & Contraindications
Significant drug interactions: strongly induces CYP3A4 and P-glycoprotein, reducing plasma levels of many drugs including oral contraceptives, antiretrovirals, cyclosporine, warfarin, and digoxin. May cause photosensitivity (fair-skinned individuals). Do not combine with SSRIs, SNRIs, or MAOIs (serotonin syndrome risk). Avoid in bipolar disorder.
Duke (2002) rates St. John's wort as ++ (raised from earlier editions) and notes antidepressant, antiviral, antibacterial, and wound-healing activities at experimental and clinical levels. Hypericin and hyperforin are identified as key active constituents. Clinical evidence (score 2) confirms antidepressant efficacy in mild-to-moderate depression, and WHO/Commission E provide approval for this indication. Dose: 300 mg standardized extract (0.3% hypericin, 3–5% hyperforin) three times daily. Duke emphasizes the critical drug interaction: St. John's wort is a potent CYP3A4 inducer and can significantly reduce blood levels of many medications including oral contraceptives, cyclosporine, antiretrovirals, and warfarin. Avoid combined use with SSRIs (serotonin syndrome risk) and pharmaceutical antidepressants (Duke, 2002).
Generally very safe for adults. Theoretically may interact with thyroid medications and sedatives. Avoid high therapeutic doses during pregnancy. Long-term safety data beyond a few months is limited.
External Ids
Botanical Description
Erect, branching perennial herb with paired, oval leaves dotted with tiny translucent oil glands that look like pinpricks when held to the light (giving the species name 'perforatum'). Bright yellow, five-petalled flowers with numerous stamens and black dots along the petal edges are borne in flat-topped clusters, and release a reddish pigment when crushed.[4]
Perennial herb, 30-70 (up to 150) cm tall, with square, branched, hairy stems typical of the mint family. Leaves are opposite, ovate to heart-shaped with a toothed margin, wrinkled and softly hairy, releasing a strong lemon scent when crushed. Small, pale yellow to white, two-lipped flowers are borne in loose whorls in the leaf axils. The fruit splits into four small nutlets.[6]
Habitat
Grows in grassland, roadsides, woodland clearings and waste ground on well-drained soils; native to Europe, Western Asia and North Africa and widely naturalised elsewhere, including North America and Australia.[4]
Native to southern Europe, the Mediterranean and western Asia, widely cultivated and naturalised in gardens, hedgebanks and waste ground across temperate regions, favouring sunny to lightly shaded, well-drained soils.[6]
Harvesting
The flowering tops (flower and upper leaf) are cut in summer as the flowers open, around the traditional St John's Day period, and dried quickly in a warm, shaded, airy place to preserve the hypericin and hyperforin content.[4]
Leaves and flowering tops are cut just before or at the start of flowering (summer), when the volatile-oil content is highest, and dried quickly at low temperature away from direct light, since the aromatic oil is heat- and light-sensitive.[6]
Traditional Uses
St John's wort has a centuries-long European folk reputation as a wound-healing and nerve tonic herb, traditionally used for mild wounds, burns and nerve pain and to lift low mood; this traditional mood-supporting use is now one of the most extensively clinically studied applications of any herbal medicine, with standardised extracts shown comparable to conventional antidepressants for mild-to-moderate depression.[1, 4]
Lemon balm has a long European tradition as a calming, 'cheering' herb for nervous tension, poor sleep and mild anxiety, and as a carminative for indigestion, bloating and cramping; topically it has traditionally been applied to cold sores. Modern clinical trials support anxiolytic and mood-related benefits and antiviral activity against herpes simplex virus, consistent with these traditional uses.[4, 6, 9]
Preparations
Flowering-top extract standardised to hypericin and/or hyperforin content, taken as tablets or capsules; the best-studied clinical form for mood support.
Dried leaf steeped in hot water, the classic way of taking lemon balm for calming and digestive support.
Encapsulated dry extract, the form used in clinical trials studying lemon balm for anxiety and mood; follow product-specific dosing.
Concentrated leaf extract cream applied to cold sores (herpes labialis) at the earliest sign of an outbreak.
Tincture of the dried leaf, 2-6 ml one to three times daily per the EU herbal monograph. Educational reference only, not a prescription.
Dosage
Clinical trials for mild-to-moderate depression commonly use around 300 mg of standardised extract three times daily (900 mg/day total); given extensive drug interactions, use should be discussed with a healthcare provider, especially alongside other medicines. Educational reference only, not a prescription.
The EU herbal monograph gives 1.5-4.5 g of the comminuted leaf in 150 mL of boiling water as an infusion, 1-3 times daily, in adolescents over 12, adults and elderly; a liquid extract at 2-4 mL and a tincture at 2-6 mL, both 1-3 times daily, are also listed. If symptoms persist longer than 2 weeks a healthcare practitioner should be consulted. Not recommended under 12 years. Educational reference only, not a prescription.
Drug Class Interactions
References
Pairings
St John's wort raises serotonin activity and can cause serotonin syndrome when combined with other serotonin-boosting agents; pairing it with another mood-active, serotonergic herb such as saffron may add to this risk.[30]
St John's wort is a strong enzyme inducer and increases serotonin activity; combining it with another antidepressant-type herb such as rhodiola may add to serotonergic effects and unpredictably change how each is handled by the body.[30]
St John's wort speeds up the breakdown of many substances and also raises serotonin activity; pairing it with a sedative herb such as valerian may add to drowsiness and can unpredictably change how each is handled by the body.[30, 31]
St John's wort is a strong enzyme inducer and kava is a liver-metabolised sedative; combining them may add to central-nervous-system effects and alter how kava is processed, so combined use warrants caution.[30, 31]
Lemon balm and passionflower are both gentle, GABA-acting calming herbs often blended together in anti-anxiety and sleep formulas; combined use may deepen relaxation but also add to drowsiness.[17, 19]
Lookalikes Review
References & Sources
- Ng, Q.X., Venkatanarayanan, N. and Ho, C.Y.X (2017) 'Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis', Journal of Affective Disorders, 210, pp. 211-221. doi:10.1016/j.jad.2016.12.048 Meta-analysis / review
https://doi.org/10.1016/j.jad.2016.12.048 - Kholghi, G., Arjmandi-Rad, S., Zarrindast, M.R. and Vaseghi, S (2022) 'St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?', Naunyn-Schmiedeberg's Archives of Pharmacology, 395(6), pp. 629-642. doi:10.1007/s00210-022-02229-z Traditional / reference
https://doi.org/10.1007/s00210-022-02229-z - Fugh-Berman, A (2000) 'Herb-drug interactions', Lancet, 355(9198), pp. 134-138. doi:10.1016/S0140-6736(99)06457-0 Traditional / reference
https://doi.org/10.1016/S0140-6736(99)06457-0 - Nobakht, S.Z., Akaberi, M., Mohammadpour, A.H., Tafazoli Moghadam, A. and Emami, S.A (2022) 'Hypericum perforatum: Traditional uses, clinical trials, and drug interactions', Iranian Journal of Basic Medical Sciences, 25(9), pp. 1045-1058. doi:10.22038/IJBMS.2022.65112.14338 Meta-analysis / review
https://doi.org/10.22038/IJBMS.2022.65112.14338 - Jiang, Z., Wang, F., Zhao, Y., Lu, L., Jiang, X., Huang, T., Lin, Y., Guo, L., Weng, Z. and Liu, E (2024) 'Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFkB-NLRP2-Caspase1-IL1beta pathway', Phytomedicine, 132, pp. 155847. doi:10.1016/j.phymed.2024.155847 Preclinical
https://doi.org/10.1016/j.phymed.2024.155847 - Oliveira, A.I., Pinho, C., Sarmento, B. and Dias, A.C.P (2016) 'Neuroprotective Activity of Hypericum perforatum and Its Major Components', Frontiers in Plant Science, 7, pp. 1004. doi:10.3389/fpls.2016.01004 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.01004 - Russo, E., Scicchitano, F., Whalley, B.J., Mazzitello, C., Ciriaco, M., Esposito, S., Patane, M., Upton, R., Pugliese, M., Chimirri, S., Mammi, M., Palleria, C. and De Sarro, G (2013) 'Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions', Phytotherapy Research, 28(5), pp. 643-655. doi:10.1002/ptr.5050 Meta-analysis / review
https://doi.org/10.1002/ptr.5050 - Saddiqe, Z., Naeem, I. and Maimoona, A (2010) 'A review of the antibacterial activity of Hypericum perforatum L', Journal of Ethnopharmacology, 131(3), pp. 511-521. doi:10.1016/j.jep.2010.07.034 Meta-analysis / review
https://doi.org/10.1016/j.jep.2010.07.034 - Mennini, T. and Gobbi, M (2004) 'The antidepressant mechanism of Hypericum perforatum', Life Sciences, 75(9), pp. 1021-1027. doi:10.1016/j.lfs.2004.04.005 Meta-analysis / review
https://doi.org/10.1016/j.lfs.2004.04.005 - Liu, Y., Jiang, Y., Huang, R., Yang, J., Xiao, B. and Dong, J (2013) 'Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety', Climacteric, 17(4), pp. 325-335. doi:10.3109/13697137.2013.861814 Meta-analysis / review
https://doi.org/10.3109/13697137.2013.861814 - Wurglics, M. and Schubert-Zsilavecz, M (2006) 'Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients', Clinical Pharmacokinetics, 45(5), pp. 449-468. doi:10.2165/00003088-200645050-00002 Meta-analysis / review
https://doi.org/10.2165/00003088-200645050-00002 - Kasper, S (2001) 'Hypericum perforatum - a review of clinical studies', Pharmacopsychiatry, 34(Suppl 1), pp. S51-S55. doi:10.1055/s-2001-15467 Meta-analysis / review
https://doi.org/10.1055/s-2001-15467 - Nathan, P (1999) 'The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.)', Molecular Psychiatry, 4(4), pp. 333-338. doi:10.1038/sj.mp.4000557 Meta-analysis / review
https://doi.org/10.1038/sj.mp.4000557 - Verotta, L (2003) 'Hypericum perforatum, a source of neuroactive lead structures', Current Topics in Medicinal Chemistry, 3(2), pp. 187-201. doi:10.2174/1568026033392589 Meta-analysis / review
https://doi.org/10.2174/1568026033392589 - Linde, K. et al (2008) 'St John'. Traditional / reference
https://scholar.google.com/scholar?q=St%20John - Natural Standard (2013) 'Hypericum perforatum (St'. Traditional / reference
https://scholar.google.com/scholar?q=Hypericum%20perforatum%20%28St - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Zhou, S., Chan, E., Pan, S.Q., Huang, M. and Lee, E.J.D (2004) 'Pharmacokinetic interactions of drugs with St John's wort', Journal of Psychopharmacology, 18(2), pp. 262-276. doi:10.1177/0269881104042632 Meta-analysis / review
https://doi.org/10.1177/0269881104042632 - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Borrelli, F. and Izzo, A.A (2009) 'Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations', The AAPS Journal, 11(4), pp. 710-727. doi:10.1208/s12248-009-9146-8 Meta-analysis / review
https://doi.org/10.1208/s12248-009-9146-8 - Nicolussi, S., Drewe, J., Butterweck, V. and Meyer zu Schwabedissen, H.E (2020) 'Clinical relevance of St. John's wort drug interactions revisited', British Journal of Pharmacology, 177(6), pp. 1212-1226. doi:10.1111/bph.14936 Meta-analysis / review
https://doi.org/10.1111/bph.14936 - Piscitelli, S.C., Burstein, A.H., Chaitt, D., Alfaro, R.M. and Falloon, J (2000) 'Indinavir concentrations and St John's wort', Lancet, 355(9203), pp. 547-548. doi:10.1016/S0140-6736(99)05712-8 Clinical study
https://doi.org/10.1016/S0140-6736(99)05712-8 - Barone, G.W., Gurley, B.J., Ketel, B.L., Lightfoot, M.L. and Abul-Ezz, S.R (2000) 'Drug interaction between St. John's wort and cyclosporine', Annals of Pharmacotherapy, 34(9), pp. 1013-1016. doi:10.1345/aph.10088 Clinical study
https://doi.org/10.1345/aph.10088 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Pfrunder, A., Schiesser, M., Gerber, S., Haschke, M., Bitzer, J. and Drewe, J (2003) 'Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial', British Journal of Clinical Pharmacology, 56(6), pp. 683-690. doi:10.1046/j.1365-2125.2003.02005.x Randomized trial
https://doi.org/10.1046/j.1365-2125.2003.02005.x - Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M. and Roots, I (1999) 'Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)', Clinical Pharmacology and Therapeutics, 66(4), pp. 338-345. doi:10.1053/cp.1999.v66.a101944 Clinical study
https://doi.org/10.1053/cp.1999.v66.a101944 - Mathijssen, R.H.J., Verweij, J., de Bruijn, P., Loos, W.J. and Sparreboom, A (2002) 'Effects of St. John's wort on irinotecan metabolism', Journal of the National Cancer Institute, 94(16), pp. 1247-1249. doi:10.1093/jnci/94.16.1247 Randomized trial
https://doi.org/10.1093/jnci/94.16.1247 - Smith, P., Bullock, J.M., Booker, B.M., Haas, C.E., Berenson, C.S. and Jusko, W.J (2004) 'The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate', Pharmacotherapy, 24(11), pp. 1508-1514. doi:10.1592/phco.24.16.1508.50958 Clinical study
https://doi.org/10.1592/phco.24.16.1508.50958 - Izzo, A.A (2004) 'Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence', International Journal of Clinical Pharmacology and Therapeutics, 42(3), pp. 139-148. doi:10.5414/cpp42139 Meta-analysis / review
https://doi.org/10.5414/cpp42139 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
- Mathews, I.M., Eastwood, J., Lamport, D.J., Cozannet, R.L. and others (2024) 'Clinical Efficacy and Tolerability of Lemon Balm (Melissa officinalis L.) in Psychological Well-Being: A Review', Nutrients, 16(20), pp. 3545. doi:10.3390/nu16203545 Meta-analysis / review
https://doi.org/10.3390/nu16203545 - Ghazizadeh, J., Sadigh-Eteghad, S., Marx, W., Fakhari, A. and others (2021) 'The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis', Phytotherapy Research, 35(12), pp. 6690-6705. doi:10.1002/ptr.7252 Meta-analysis / review
https://doi.org/10.1002/ptr.7252 - Shahsavari, K., Shams Ardekani, M.R., Khanavi, M., Jamialahmadi, T. and others (2024) 'Effects of Melissa officinalis (lemon balm) consumption on serum lipid profile: a meta-analysis of randomized controlled trials', BMC Complementary Medicine and Therapies, 24(1), pp. 146. doi:10.1186/s12906-024-04442-0 Meta-analysis / review
https://doi.org/10.1186/s12906-024-04442-0 - Petrisor, G., Motelica, L., Craciun, L.N., Oprea, O.C. and others (2022) 'Melissa officinalis: Composition, Pharmacological Effects and Derived Release Systems-A Review', International Journal of Molecular Sciences, 23(7), pp. 3591. doi:10.3390/ijms23073591 Meta-analysis / review
https://doi.org/10.3390/ijms23073591 - Heshmati, J., Morvaridzadeh, M., Sepidarkish, M., Fazelian, S. and others (2020) 'Effects of Melissa officinalis (Lemon Balm) on cardio-metabolic outcomes: A systematic review and meta-analysis', Phytotherapy Research, 34(12), pp. 3113-3123. doi:10.1002/ptr.6744 Meta-analysis / review
https://doi.org/10.1002/ptr.6744 - Shakeri, A., Sahebkar, A. and Javadi, B (2016) 'Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology', Journal of Ethnopharmacology, 188, pp. 204-228. doi:10.1016/j.jep.2016.05.010 Meta-analysis / review
https://doi.org/10.1016/j.jep.2016.05.010 - Zam, W., Quispe, C., Sharifi-Rad, J., Lopez, M.D. and others (2022) 'An Updated Review on The Properties of Melissa officinalis L.: Not Exclusively Anti-anxiety', Frontiers in Bioscience (Scholar Edition), 14(2), pp. 16. doi:10.31083/j.fbs1402016 Meta-analysis / review
https://doi.org/10.31083/j.fbs1402016 - Chang, J.Y., Balch, C., Puccio, J. and Oh, H.S (2023) 'A Narrative Review of Alternative Symptomatic Treatments for Herpes Simplex Virus', Viruses, 15(6), pp. 1314. doi:10.3390/v15061314 Meta-analysis / review
https://doi.org/10.3390/v15061314 - Ulbricht, C., Brendler, T., Gruenwald, J., Kligler, B. and others (2005) 'Lemon balm (Melissa officinalis L.): an evidence-based systematic review by the Natural Standard Research Collaboration', Journal of Herbal Pharmacotherapy, 5(4), pp. 71-114. doi:10.1080/j157v05n04_08 Meta-analysis / review
https://doi.org/10.1080/j157v05n04_08 - Stojanovic, N.M., Mladenovic, M.Z., Maslovaric, A., Stojiljkovic, N.I. and others (2021) 'Lemon balm (Melissa officinalis L.) essential oil and citronellal modulate anxiety-related symptoms - In vitro and in vivo studies', Journal of Ethnopharmacology, 284, pp. 114788. doi:10.1016/j.jep.2021.114788 Preclinical
https://doi.org/10.1016/j.jep.2021.114788 - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Melissa officinalis L., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-melissa-officinalis-l-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-melissa-officinalis-l-folium_en.pdf - Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
https://scholar.google.com/scholar?q=Medical%20Herbalism - Kennedy, D.O. et al (2002) 'Modulation of mood and cognitive performance following acute administration of Melissa officinalis', 27(2), pp. 256--261. doi:10.1016/s0091-3057(02)00777-3 Randomized trial
https://doi.org/10.1016/s0091-3057(02)00777-3 - Petersen, M. and Simmonds, M.S.J (2003) 'Rosmarinic acid', 62(2), pp. 121--125. Traditional / reference
https://scholar.google.com/scholar?q=Rosmarinic%20acid - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Haybar, H., Javid, A.Z., Haghighizadeh, M.H., Valizadeh, E., Mohaghegh, S.M. and Mohammadzadeh, A (2018) 'The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina', Clinical Nutrition ESPEN, 26, pp. 47-52. doi:10.1016/j.clnesp.2018.04.015 Randomized trial
https://doi.org/10.1016/j.clnesp.2018.04.015 - Keck, M.E., Nicolussi, S., Spura, K., Blohm, C., Zahner, C. and Drewe, J (2020) 'Effect of the fixed combination of valerian, lemon balm, passionflower, and butterbur extracts (Ze 185) on the prescription pattern of benzodiazepines in hospitalized psychiatric patients', Phytotherapy Research, 34(6), pp. 1436-1445. doi:10.1002/ptr.6618 Clinical study
https://doi.org/10.1002/ptr.6618
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.